A device for generating predetermined wave forms

Abstract

The invention relates to an apparatus for generating output wave forms for application to a target area via electrodes. More particularly, the invention relates to a device that is capable of being modified to generate select wave forms for treating one or more health conditions, medical conditions, or specific diseases using a non-invasive and surface level application of the device.

Description

[0001] A DEVICE FOR GENERATING PREDETERMINED WAVE FORMS

[0002] FIELD OF APPLICATION OF THE INVENTION

[0003] The present invention relates to a device for generating predetermined wave forms. More particularly, the invention relates to a device that is capable of being modified to generate select wave forms for treating one or more health conditions, medical conditions, or specific diseases using a non-invasive and surface level application of the device.

[0004] BACKGROUND TO THE INVENTION

[0005] The history of devices capable of generating frequencies or waveforms for treating diseases and organisms in humans dates back over a century, encompassing a diverse range of scientific approaches, technological innovations, and medical theories. These developments span from early experimental therapies in the 19th century to modern-day advancements in frequency-based treatments, which are now being investigated for their potential to target specific pathogens, enhance cell regeneration, and mitigate the effects of chronic diseases. Over time, these technologies have evolved from rudimentary devices to sophisticated instruments capable of precise frequency generation, influenced by discoveries in physics, biology, and electrical engineering.

[0006] The earliest explorations into the use of frequencies and waveforms for healing purposes can be traced back to the work of Dr. Georges Lakhovsky in the early 20th century. Lakhovsky, a Russian engineer, postulated that all living cells emit electromagnetic radiation and that these oscillations could be disrupted by diseasecausing organisms. He believed that restoring the natural oscillations of cells could promote health and combat illness. In 1925, Lakhovsky invented the "Multi-Wave Oscillator," a device designed to generate multiple frequencies simultaneously to stimulate the body's natural healing processes. He claimed that the Multi-Wave Oscillator could restore cellular vitality and help cure a wide range of ailments by boosting the oscillatory frequency of cells. Although Lakhovsky's ideas were not widely accepted in mainstream medicine, his work laid an early foundation for future studies into the therapeutic effects of electromagnetic fields and frequencies.

[0007] Another significant figure in the early history of frequency-based therapies was Royal Raymond Rife, an American scientist who, during the 1930s, developed the Rife Machine. Rife's invention was based on his theory that every microorganism, such as bacteria and viruses, has a unique electromagnetic frequency. He believed that if the specific frequency of a pathogen could be identified, it could be destroyed by exposing it to a resonant frequency, much like how a glass can shatter when exposed to a sound wave at its resonant frequency. Rife claimed to have developed a microscope that allowed him to visually observe pathogens being destroyed by specific frequencies. His Rife Machine was designed to generate these frequencies and target diseasecausing microorganisms in the body, potentially offering a non-invasive treatment for infections and other conditions. While Rife's work attracted considerable attention at the time, it was met with scepticism from the medical community, and the lack of rigorous scientific validation ultimately led to the marginalization of his theories. However, Rife’s concept of resonant frequency treatment continues to influence modem alternative medicine and has inspired further research into the therapeutic potential of frequency-based devices.

[0008] In the mid-20th century, technological advancements in electronics and biophysics paved the way for more sophisticated devices capable of generating frequencies for medical purposes. The development of electrotherapy and bioelectromagnetic therapies gained traction during this period, as researchers began to explore the effects of electromagnetic fields on biological systems. These therapies, which include techniques such as transcutaneous electrical nerve stimulation (TENS) and pulsed electromagnetic field therapy (PEMF), use controlled electrical currents or electromagnetic fields to stimulate nerves, reduce pain, and promote tissue healing. TENS devices, for example, deliver low-voltage electrical impulses to nerves in order to block pain signals from reaching the brain, while PEMF devices emit electromagnetic pulses to enhance cellular repair and reduce inflammation. Both of these modalities have become widely used in physical therapy and pain management, illustrating the growing acceptance of frequency-based treatments in mainstream medicine.

[0009] The second half of the 20th century also saw the emergence of bioresonance therapy, a controversial alternative medicine technique that builds upon the theories of Lakhovsky and Rife. Bioresonance devices purportedly measure the electromagnetic frequencies emitted by a patient’s body, diagnose imbalances or disruptions caused by illness, and then apply therapeutic frequencies to correct these imbalances. Proponents of bioresonance therapy claim that it can be used to treat a variety of conditions, from allergies and digestive disorders to chronic fatigue and autoimmune diseases. However, like its predecessors, bioresonance therapy has been criticized for lacking scientific evidence and has been classified as pseudoscientific by many medical professionals. Despite this, bioresonance devices are still used in some alternative medicine practices, and ongoing research continues to investigate the potential for frequency-based therapies to modulate biological processes.

[0010] In parallel with these developments, the field of low-level laser therapy (LLLT), also known as photobiomodulation, began to emerge as a promising area of research in the late 20th century. LLLT involves the use of specific wavelengths of light, often in the form of laser or LED devices, to stimulate cellular activity and promote tissue healing. While LLLT does not generate frequencies in the same manner as electromagnetic field devices, it operates on the principle that light energy can be absorbed by cellular components, leading to biochemical changes that enhance the body's natural healing processes. LLLT has been studied for its potential to treat a wide range of conditions, including musculoskeletal pain, wound healing, and inflammatory diseases. Clinical studies have demonstrated that specific light wavelengths can increase the production of adenosine triphosphate (ATP) in cells, reduce oxidative stress, and modulate immune responses, providing a scientific basis for its therapeutic effects. Although LLLT differs from traditional frequency-based devices, it shares the common goal of harnessing energy to influence biological systems and improve health outcomes.

[0011] As the 21st century progressed, advances in bioelectronics, nanotechnology, and quantum physics further expanded the possibilities for devices that generate frequencies and waveforms to treat diseases and organisms in humans. One of the most significant areas of research in this regard is the development of frequencyspecific microcurrent (FSM) therapy, a technique that uses extremely low-level electrical currents to target specific tissues and promote healing. FSM devices deliver frequencies in the microampere range, which are thought to mimic the body’s own electrical signals and facilitate cellular repair. This approach has been studied for its potential to reduce pain, inflammation, and scar tissue in conditions such as fibromyalgia, sports injuries, and neuropathic pain. Unlike earlier frequency-based therapies, FSM has gained more acceptance within the medical community, with some studies suggesting that it may have a beneficial effect on pain reduction and tissue healing. However, further research is needed to fully understand its mechanisms of action and therapeutic efficacy.

[0012] Another cutting-edge development in the field of frequency-based therapies is the use of ultrasound and focused ultrasound (FUS) technologies to treat diseases. Ultrasound waves are mechanical vibrations that can penetrate tissues, and they have been used for decades in diagnostic imaging as well as in therapeutic applications such as lithotripsy (the breaking up of kidney stones). In recent years, focused ultrasound has gained attention for its potential to non-invasively treat tumours, neurological disorders, and other conditions by precisely targeting tissues with high-intensity sound waves. FUS devices can generate ultrasound frequencies that produce thermal or mechanical effects, leading to the destruction of diseased tissue while sparing surrounding healthy areas. Clinical trials are currently underway to investigate the use of FUS in treating conditions such as Parkinson's disease, Alzheimer’s disease, and certain types of cancer, positioning ultrasound technology as a promising tool in the realm of frequency-based medical treatments. In addition to ultrasound, recent advances in quantum biology have led to the exploration of quantum frequency devices for health applications. Quantum biology is an emerging field that examines how quantum mechanical principles, such as superposition and entanglement, may influence biological processes at the molecular level. Quantum frequency devices, still largely experimental, are designed to generate specific frequencies that interact with biological systems in novel ways, potentially influencing cellular communication, energy transfer, and immune responses. While these devices are in the early stages of development, researchers are optimistic that quantum technologies could open up new frontiers in the treatment of diseases, particularly those that are difficult to address with conventional therapies.

[0013] The above solutions lack evidence through significant research. Moreover, the solutions above require expensive instruments and prolonged procedures, rendering them unfeasible in practice.

[0014] Given the above, it is clear that there exists a present need for a system that is capable of being used by any individual, which is capable of treating a variety of conditions and diseases through a simple procedure.

[0015] OBJECT OF THE INVENTION

[0016] Accordingly, it is an object of the present invention to provide a device that is capable of generating predetermined wave forms for treating one or more health conditions, medical conditions, or specific diseases. SUMMARY OF THE INVENTION

[0017] As used herein, the singular forms “a,” “an,” and “the” are intended to include the plural forms as well, unless expressly stated otherwise. It will be further understood that the terms “includes,” “comprises,” “including,” and / or “comprising,” when used in this specification, specify the presence of stated features, integers, steps, operations, elements, and / or components, but do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components, and / or groups thereof. It will be understood that when an element is referred to as being “connected” or “coupled” to another element, it can be directly connected or coupled to the other element or intervening elements may be present. Furthermore, “connected” or “coupled” as used herein may include wirelessly connected or coupled. As used herein, the term “and / or” includes any and all combinations of one or more of the associated listed items.

[0018] According to a first aspect thereof, there is provided a wave form generating device suitable for treating a target area, the device comprising:

[0019] - a power source communicatively coupled to a control unit, wherein the control unit comprises a memory for storing one or more treatment protocols, each treatment protocol defining one or more wave form parameters, and wherein the control unit comprises a processor;

[0020] - a user input means communicatively coupled to the control unit which allows a user to select a treatment protocol;

[0021] - a wave form generating means communicatively coupled to the processor and the memory, wherein the processor controls the wave form generating means to generate one or more output wave forms in accordance with the selected treatment protocol;

[0022] - one or more electrodes electrically coupled to the wave form generating means, wherein the one or more electrodes are capable of being manipulated by the user apply the one or more output wave forms to the target area; and

[0023] - an indicator configured to generate a notification when the selected treatment protocol has concluded.

[0024] The device may further comprise a protocol module communicatively coupled to the processor and the wave form generating means, the protocol module being configured to authenticate a selected treatment protocol and permit generation of the one or more output wave forms when the selected treatment protocol has been successfully authenticated.

[0025] The target area may be an organism or a resource. The organism may be selected from the group consisting of mammals, birds, reptiles, amphibians, fish, invertebrates, fungi, bacteria, viruses, protozoa, parasites, plants, or combinations thereof. The resource may be selected from the group consisting of water, food, minerals, soil, or combinations thereof.

[0026] The power source may be a battery, AC power supply, DC power supply, solar panel, fuel cell, or combinations thereof. The battery may be rechargeable.

[0027] The control unit may comprise a microcontroller, microprocessor, circuits, or combinations thereof. The wave form parameters may comprise properties of a wave form selected from the group consisting of frequency, amplitude, waveform shape, cycle, phase, pulse width, current, modulation, wavelength, polarity, or combinations thereof.

[0028] The frequency may be between 100 000Hz and 1 000 000 Hz.

[0029] The amplitude may be between 1 and 27 Volts.

[0030] The waveform shape may be selected from a sine wave form, a cosine wave form, a modified sine wave form, a modified cosine wave form, or a custom wave form. Other waveforms may be used, where these waveforms may be development and / or generated with further development on a Direct Digital Synthesis (“DDS”).

[0031] The cycles may be between 1 and 10.

[0032] The phase may be X and Y and / or Z and X. Y may be between 100 000Hz and 1 000 000 Hz.

[0033] The pulse width may be directly correlated to the frequency value. The pulse width may e between 0 and 500ns.

[0034] The current may allow for a wave between 1 and 27 volts.

[0035] The modulation of the wave may be amplitude modulation, frequency modulation, or a combination thereof. The modulation of the wave mya be a multiplication of 100 of the base frequency of the wave.

[0036] The wavelength of the wave form may be between 0 and 150 meters.

[0037] The polarity of the wave may be single sided.

[0038] Differential signal generation or differential waveforms may be developed or modified by DDS technology. The device may include a graphical user interface for displaying the wave form parameters to a user, wherein the user may select the wave form parameters by using the user input instructions to feed instructions to the control unit.

[0039] In the conductive embodiments described herein, waveform delivery is effected via a closed electrical path between electrodes and the device does not employ an intentional RF antenna. References to “wavelength” are to the characteristic wavelength associated with the operating frequency of the time-varying signal, either in free space or, where relevant, in the target medium, and are used as a descriptor of the frequency regime and for design constraints rather than to imply radiative transmission. The control unit may select operating frequencies such that the associated wavelength is large relative to the electrode spacing and lead lengths, thereby maintaining quasi-static, predominantly conductive coupling and minimising unintended radiation. For the frequencies employed by the selected treatment protocols, the associated wavelength can be considered to lie within the claimed range up to 150 metres, and the device incorporates shielding and cable management to ensure emissions remain within applicable limits.

[0040] The wave form generating means may be one or more electrodes. The electrodes may be direct contact electrodes. The electrodes may be attachable to a target area for receiving the generated wave form or wave forms.

[0041] The device may comprise a timing module stored on the memory which allows for a set of instructions to be executed by the processor which allows for one or more wave forms to be generating according to a predetermined timing program. The timing program may allow for the one or more wave forms to be released according to predetermined timing interval.

[0042] The device may further comprise indication means for indicating when a treatment is being actively applied to a target area, and when the treatment is complete. The indication means may be a light alert notification, a sound alert notification, or a combination thereof.

[0043] The device may further comprise transmission means for transmitting data, parameters and instructions from the control unit to an external device.

[0044] The device may comprise an enclosure for enclosing the device.

[0045] The device may further comprise a wave form enhancer device. The wave form enhancer device may a frequency amplifier device.

[0046] The one or more output wave form may be a modified square wave.

[0047] The above and other characteristics, features and advantages of the present invention will become apparent from the following detailed description, taken in conjunction with the accompanying drawing which illustrate, by way of example, the principles of the invention. This description is given for the sake of example only, without limiting the scope of the invention. The reference figures quoted below refer to the attached drawings. BRIEF DESCRIPTION OF THE DRAWINGS

[0048] Preferred embodiments of the invention are described below with reference to the accompanying figures, wherein:

[0049] Figure 1 is a block diagram of the wave form generating device;

[0050] Figure 2 is a schematic illustration of the circuit utilised in the wave form generating device;

[0051] Figure 3 is a perspective view of the wave form generating device;

[0052] Figure 4 is an illustration of the wave form generating device and its probe units;

[0053] Figure 5 is a first image of test lab results; and

[0054] Figure 6 is a second image of test lab results.

[0055] The presently disclosed subject matter will now be described more fully hereinafter with reference to the accompanying Examples, in which representative embodiments are shown. The presently disclosed subject matter can, however, be embodied in different forms and should not be construed as limited to the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the embodiments to those skilled in the art.

[0056] DESCRIPTION OF PREFERRED EMBODIMENTS OF THE INVENTION

[0057] A non-limiting example of a preferred embodiment of the invention is described in more detail below, with reference to Figures 1 to 6. With reference to Figure 1 , there is provided a wave form generating device 2 comprising a processor unit 4, wave generation means 6, power source 8 comprising multiple batteries, a rechargeable battery management system 10 (comprising a Lithium Polymer battery) for managing the charging process of the rechargeable battery, a charging port 12, a graphical user interface 14, transmission means 16, and two probes 18 for applying the wave form treatment. With reference to Figure 2, there is provided a schematic illustration of a circuit board 20 used in the wave form generating device.

[0058] In certain embodiments, the probes (operating as electrodes) are hand-held probes attached to the device by flexible leads. In a bipolar mode, a user holds a respective probe in each hand so that the target area completes a closed conductive path between the probes, and the processor controls the wave form generating means to apply the one or more output wave forms across the probes in accordance with the selected treatment protocol. In a monopolar mode, a user holds a single hand-held probe while a return electrode is placed on the body at a remote location to complete the conductive path. The control unit monitors contact and impedance between the electrodes and inhibits waveform generation unless a valid conductive path is detected.

[0059] With reference to Figure 3, is provided a wave form generating device 2 comprising a camera 22, a speaker 24, a screen 26, a probe pocket 28, 1 of 2 probes 30, probe contact points 32, and an audio jack 34. With reference to Figure 4, is provided a wave form generating device 2 comprising its circuit board 20 and the probes 30 having pulsing LED lights 36.

[0060] Software control architecture and secure protocol execution

[0061] In certain embodiments, the device operates under a software control architecture that governs how treatment protocols are provisioned, selected, executed and recorded. In these embodiments, a treatment protocol is represented as a data package that contains the waveform parameters to be applied by the device, together with metadata defining timing, repetition, and permissible bounds for the parameters. The device is configured to execute only a treatment protocol that has been authenticated by the system, so that unauthorised or altered protocols cannot be applied to a target area. Authentication may rely on secure verification of the provenance and integrity of a protocol data package before the device will enable execution. At run-time the control unit evaluates any candidate parameter values against the operating space defined by the authenticated treatment protocol and inhibits waveform generation if a value falls outside the operating space, optionally issuing a user alert.

[0062] The device may further restrict local users from altering protocol parameters beyond specified bounds and may prevent execution if supplied parameters fall outside permitted ranges. During execution, the device may record session data, including the protocol identification, selected parameter values, timing, and completion status, so that an accurate record of use is maintained. The device may be arranged to receive updated protocol data packages or software updates from an external system over a communication link and to apply such updates only after successful verification. In embodiments intended for supervised use, protocol selection can be limited to those protocols that have been approved by a clinician and made available to the device for execution.

[0063] In certain embodiments, a “treatment protocol” is represented on the device as a data package that specifies the waveform parameters to be applied by the device together with any permitted bounds for adjustment, timing and repetition rules, and an identifier of the protocol’s approval status. Before any protocol can be executed, the device performs an authentication step to verify that the protocol presented to it is approved for use on the device and has not been altered. The authentication may include verification of the provenance and integrity of the protocol data package and confirmation that it corresponds to an approved protocol available to the device. Only after successful authentication will the device enable execution of that protocol. During execution, the control software enforces the permitted bounds contained in the authenticated protocol so that local user input cannot set waveform parameters outside those bounds. This arrangement prevents unauthorised or altered protocols from being applied, helps ensure that only approved parameter sets are delivered, and supports clinical governance and safety by recording the identity of the protocol used and the parameters applied

[0064] In certain embodiments, the device operates within a restricted parameter architecture that is designed to produce predictable and repeatable therapeutic effects. In these embodiments, the selectable operating space for signal parameters, including frequency, amplitude, modulation type and rate, waveform shape, pulse width, duty cycle, and treatment duration, is defined by the selected treatment protocol and enforced by the control unit at run-time. The device does not execute parameter values outside the defined operating space. This arrangement ensures that waveform generation is confined to a defined parameter set, thereby supporting consistent delivery of the intended therapeutic signal characteristics across sessions and users. The defined operating space includes, at a minimum, the permitted ranges for frequency, amplitude and modulation type and rate for the selected treatment protocol.

[0065] Each treatment protocol corresponds to a targeted signal profile associated with a specific physiological function or intended clinical outcome. A targeted signal profile comprises one or more signal parameters and, where applicable, permitted bounds for user adjustment together with timing and repetition rules. During execution of a protocol, the control unit applies the targeted signal profile as defined and enforces any permitted bounds so that the applied parameters remain within the defined parameter set. By constraining operation to the targeted signal profile and recording the applied parameters and timing, the device supports predictable and repeatable therapeutic effects.

[0066] If you wish to reflect the contrast with general-purpose stimulators, you can add one bridging sentence, kept neutral in tone, to the end of the same section: In contrast to general-purpose electrical stimulators that allow unconstrained parameter selection, the device executes only selected treatment protocols and enforces their defined operating bounds to deliver reproducible signal profiles.

[0067] Patient Case Studies Ten anonymized clinical cases of female patients presenting with UTI symptoms are summarized below. Each patient underwent one or more sessions using the wave form generating device according to the present invention and urinary tract infectionspecific protocols.

[0068] Clinical data

[0069] Table - Case study 1

[0070] G039 - Urinary Tract Infection treatment code on the device. Each treatment code operates using preset therapeutic waveforms calibrated for the targeted condition. These are normally between 300 000Hz- 500 000Hz.

[0071] Outcome: Full symptom resolution withinl week. The patient came for a follow-up consult a week later regarding her chronic bladder infection. The patient reported no more UTI Infection symptoms such as urinating frequently and burning urine.

[0072] Table - Case study 2 G039 & G076 - Urinary Tract Infection treatment code on the device. Each treatment code operates using preset therapeutic waveforms calibrated for the targeted condition. These are normally between 300 000Hz- 500 000Hz.

[0073] Outcome: Symptom-free after single treatment. The Patient confirmed all symptoms stopped after a single treatment was administered.

[0074] Table - Case study 3

[0075] G039 - Urinary Tract Infection treatment code on the device. Each treatment code operates using preset therapeutic waveforms calibrated for the targeted condition. These are normally between 300 000Hz- 500 000Hz.

[0076] Outcome: Significant Improvement: Patient reported that her energy was better, also reported that UTI symptoms has dissipated.

[0077] Table - Case study 4 G039 & G076 - Urinary Tract Infection treatment code on the device. Each treatment code operates using preset therapeutic waveforms calibrated for the targeted condition. These are normally between 300 000Hz- 500 000Hz.

[0078] Outcome: Symptom-free: The patient reported her bladder discomfort is better, no more UTI symptoms. Energy levels have also improved.

[0079] Table - Case study 5

[0080] G039 - Urinary Tract Infection treatment code on the device. Each treatment code operates using preset therapeutic waveforms calibrated for the targeted condition. These are normally between 300 000Hz- 500 000Hz.

[0081] Outcome: Symptom-free: Patient presented no more UTI symptoms after treatment was completed.

[0082] Table - Case study 6 G039 & G076 - Urinary Tract Infection treatment code on the device. Each treatment code operates using preset therapeutic waveforms calibrated for the targeted condition. These are normally between 300 000Hz - 500 000Hz.

[0083] Outcome: Full Symptom Resolution: Patient came in for 3 treatment sessions and reported no more bladder discomfort.

[0084] Table - Case study 7

[0085] G039 & G076 - Urinary Tract Infection treatment code on the device. Each treatment code operates using preset therapeutic waveforms calibrated for the targeted condition. These are normally between 300 000Hz- 500 000Hz.

[0086] Outcome: Symptom-free: Patient had full symptom resolution, after 3 treatment sessions.

[0087] Table - Case study 8 G039 - Urinary Tract Infection treatment code on the device. Each treatment code operates using preset therapeutic waveforms calibrated for the targeted condition. These are normally between 300 000Hz - 500 000Hz.

[0088] Outcome: Symptom-free: Patient was symptom free by the third treatment.

[0089] Table - Case study 8

[0090] G039 - Urinary Tract Infection treatment code on the device. Each treatment code operates using preset therapeutic waveforms calibrated for the targeted condition. These are normally between 300 000Hz - 500 000Hz.

[0091] Outcome: Symptom-free: Burning urine subsided after second treatment and all symptoms have cleared.

[0092] Table - Case study 10

[0093] G039 - Urinary Tract Infection treatment code on the device. Each treatment code operates using preset therapeutic waveforms calibrated for the targeted condition. These are normally between 300 000Hz - 500 000Hz. Outcome: Symptom-free: Patient came back into the clinic a few days later and reported there was no more symptoms.

[0094] For all 10 case studies, no adverse events were reported. Three patients declined or discontinued antibiotics.

[0095] Laboratory data

[0096] Test series at laboratory in a body of water contaminated with E. coli using the below frequency and treatment codes. Note treatment was run on two different occasions with different infection sources.

[0097] With reference to the results in Figure 5, protocol P034 was administered for a total of 12 min in one session. Drastic reduction in active E.coli bacteria as illustrated above. On 15 Oct 2024, E. Co / / levels were 160 and after treatment retesting the same sample on 16 Oct 2024 E.Coli levels was less than 1 . (<1 )

[0098] P034 - E.Coli Infection treatment code on the device. Each treatment code operates using preset therapeutic waveforms calibrated for the targeted condition. These are normally between 300 000Hz - 400 000Hz.

[0099] With reference to the results in Figure 6, protocol P034 was administered for a total of 12 min in one session. Drastic reduction in active E.coli bacteria as illustrated above. On 30 July 2025 E.Coli levels were 3100 and after treatment retesting the same sample on the 30 July 2025 E.Coli levels was 41 . P034 - Is a E.Coli Infection treatment code on the device. Each treatment code operates using preset therapeutic waveforms calibrated for the targeted condition. These are typically between 300 000Hz - 400 000Hz.

[0100] As can be seen above, the test results are promising, and drastic reduction was achieved with in a few minutes.

Claims

CLAIMS1 . A wave form generating device suitable for application of one or more output wave forms to a target area, the device comprising:- a power source communicatively coupled to a control unit, wherein the control unit comprises a memory for storing one or more treatment protocols, each treatment protocol defining one or more wave form parameters, and wherein the control unit comprises a processor;- a user input means communicatively coupled to the control unit which allows a user to select a treatment protocol;- a wave form generating means communicatively coupled to the processor and the memory, wherein the processor controls the wave form generating means to generate one or more output wave forms in accordance with the selected treatment protocol;- one or more electrodes electrically coupled to the wave form generating means, wherein the one or more electrodes are capable of being manipulated by the user apply the one or more output wave forms to the target area; and- an indicator configured to generate a notification when the selected treatment protocol has concluded.

2. The wave form generating device according to claim 1 further comprising a protocol module communicatively coupled to the processor and the wave form generating means, the protocol module being configured to authenticate a selected treatment protocol and permit generation of the one or more outputwave forms when the selected treatment protocol has been successfully authenticated.

3. The wave form generating device according to claim 1 , wherein the target area is an organism or a resource, or an organism and resource in combination.

4. The wave form generating device according to claim 3, wherein the organism is selected from the group consisting of mammals, birds, reptiles, amphibians, fish, invertebrates, fungi, bacteria, viruses, protozoa, parasites, plants, or combinations thereof.

5. The wave form generating device according to claim 3, wherein the resource is selected from the group consisting of water, food, minerals, soil, or combinations thereof.

6. The wave form generating device according to claim 1 , wherein the power source is selected from the group consisting of a battery, a rechargeable battery, an AC power supply, a DC power supply, a solar panel, a fuel cell, or combinations thereof.

7. The wave form generating device according to claim 1 , wherein the control unit comprises a microcontroller, a microprocessor, and an electronic circuit.

8. The wave form generating device according to claim 1 , wherein the wave form parameters comprise wave form properties selected from the group consisting offrequency, amplitude, waveform shape, cycle, phase, pulse width, current, modulation, wavelength, polarity, or combinations thereof.

9. The wave form generating device according to claim 8, wherein the frequency is between 100 000 Hz and 1000 000 Hz.

10. The wave form generating device according to claim 8, wherein the amplitude is between 1 and 27 Volts.11 . The wave form generating device according to claim 8, wherein the cycles are between 1 and 10.

12. The wave form generating device according to claim 8, wherein the waveform shape is selected from a sine wave form, a cosine wave form, a modified sine wave form, a modified cosine wave form, a custom wave form, or combinations thereof.

13. The wave form generating device according to claim 8 comprising a first, second, and third output channel, and a relative phase between the channels is adjustable.

14. The wave form generating device according to claim 13, wherein the phases correspond to X, Y and Z axes that are selectable within a range of 0° to 360°15. The wave form generating device according to claim 14, wherein adjustment of the Y axis allows for a wave frequency between 100 000 Hz and 1000 000 Hz.

16. The wave form generating device according to claim 8, wherein the pulse width is set as a function of the selected frequency.

17. The wave form generating device according to claim 8, wherein the pulse width is between 0 and 500 ns.

18. The wave form generating device according to claim 1 configured to generate one or more output wave forms having a voltage between 1 V and 27 V.

19. The wave form generating device according to claim 1 wherein modulation is selected from the group consisting of amplitude modulation, frequency modulation, phase modulation, pulse-width modulation of an envelope, burst modulation, and on-off keying, or combinations thereof.

20. The wave form generating device according to claim 19 wherein the frequency modulation is an integer multiple of the base frequency, and preferably a multiple of 100.21 . The wave form generating device according to claim 8 wherein the wavelength of the wave form is between 0 and 150 meters.

22. The wave form generating device according to claim 8 wherein the polarity of the wave is unipolar.

23. The wave form generating device according to claim 1 further configured to generate and / or modify differential signals using direct digital synthesis technology.

24. The wave form generating device according to claim 1 further comprising a graphical user interface for displaying to a user the wave form parameters of the selected treatment protocol and allowing the user to select a desired treatment protocol.

25. The wave form generating device according to claim 1 , wherein the wave form generating means comprises a waveform engine selected from the group consisting of a direct digital synthesis (DDS) stage, a microcontroller streaming samples to a digital-to-analogue converter (DAC), a field-programmable gate array (FPGA) streaming samples to a DAC, a function-generator integrated circuit, and a high-rate pulse-width-modulated source with a smoothing filter, or combinations thereof.

26. The wave form generating device according to claim 1 , wherein the one or more electrodes are direct contact electrodes.

27. The wave form generating device according to claim 1 further comprising a timing module stored in the memory configured to cause the processor to generate one or more output wave forms according to a predetermined timing program.

28. The wave form generating device according to claim 27, wherein the timing program comprises a predetermined timing interval according to which the one or more output wave forms will be generated.

29. The wave form generating device according to claim 1 wherein the indicator is configured to indicate when the one or more output wave forms are being actively applied to the target area.

30. The wave form generating device according to claim 29, wherein the indicator is selected from the group consisting of a visual indicator, an audible indicator, a haptic indicator, and a graphical user interface message, or combinations thereof.

31. The wave form generating device according to claim 1 further comprising transmission means for transmitting data, parameters, treatment protocols, and instructions from the control unit to an external device.

32. The wave form generating device according to claim 1 further comprising an enclosure for enclosing the device.

33. The wave form generating device according to claim 1 further comprising a wave form enhancer device.

34. The wave form generating device according to claim 33 wherein the wave form enhancer device is a frequency amplifier device.

35. The wave form generating device according to claim 1 , wherein each treatment protocol defines permitted bounds for adjustment of one or more adjustable wave form parameters, and the control unit is configured to constrain any user adjustment to within the permitted bounds.

36. The wave form generating device according to claim 2, wherein authenticating the selected treatment protocol comprises verifying a criteria selected from the group consisting of an identifier associated with the selected treatment protocol, a version indicator, an integrity check associated with the selected treatment protocol, or combinations thereof.

37. The wave form generating device according to claim 1 , wherein the selected treatment protocol comprises protocol criteria selected from the group consisting of a frequency value or range, an amplitude value or range, a waveform shape, a pulse width or duty cycle, a modulation type and rate, a treatment duration, a repetition schedule, and combinations thereof.

38. The wave form generating device according to claim 27 or claim 28, wherein the selected treatment protocol specifies a wave generation duration and a repetitionschedule, and the timing module is configured to execute the wave generation duration and repetition schedule.

39. The wave form generating device according to claim 1 further comprising a transmission module configured to, upon selection of a treatment protocol via the user input means, determine whether wave form parameters associated with the selected treatment protocol are stored in the memory and, if not, establish a data connection to an external server and download, in real time, the wave form parameters associated with the selected treatment protocol to allow for the selected treatment protocol to be executed.

40. The wave form generating device according to claim 1 , wherein the one or more output wave form is a modified square wave.

Images